Ardelyx Director Receives $200K+ Stock Grant Package in Compensation Deal
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ardelyx Director William C. Bertrand Jr. reported multiple equity transactions on June 18, 2025, significantly increasing his beneficial ownership position:
- Acquired 19,390 shares of common stock at $0 through the Non-Employee Director Compensation Program, choosing stock instead of cash compensation
- Received 41,551 Restricted Stock Units (RSUs) under the same program, convertible 1:1 into common shares upon vesting
- Granted stock options to purchase 54,059 shares at $3.61 per share, expiring June 18, 2035. Options vest monthly at 1/12th rate with potential acceleration at next annual stockholder meeting
Following these transactions, Bertrand directly owns 290,707 shares of common stock and 54,059 stock options. These grants reflect standard non-employee director compensation rather than open market transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 54,059 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,390 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 41,551 | $0.00 | $0.00 |
Footnotes (4)
- F1. The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.
- F2. Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.
- F3. The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
- F4. The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions occurred for ARDX stock on June 18, 2025?
What is the exercise price and expiration date of ARDX stock options granted to Bertrand in June 2025?
What is the vesting schedule for ARDX director William Bertrand's June 2025 stock options?
How did ARDX director William Bertrand receive his common stock compensation in June 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.